MENU
+Compare
MLSS
Stock ticker: ASE
AS OF
Dec 4, 04:57 PM (EDT)
Price
$0.35
Change
+$0.01 (+2.94%)
Capitalization
27.07M

MLSS Milestone Scientific Forecast, Technical & Fundamental Analysis

Milestone Scientific Inc is a biomedical technology company... Show more

MLSS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MLSS with price predictions
Dec 03, 2025

MLSS's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for MLSS turned positive on November 28, 2025. Looking at past instances where MLSS's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MLSS's RSI Oscillator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 02, 2025. You may want to consider a long position or call options on MLSS as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where MLSS advanced for three days, in of 221 cases, the price rose further within the following month. The odds of a continued upward trend are .

MLSS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MLSS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MLSS entered a downward trend on December 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MLSS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.616) is normal, around the industry mean (9.461). P/E Ratio (0.000) is within average values for comparable stocks, (165.684). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.548). MLSS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (3.130) is also within normal values, averaging (111.186).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MLSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
MLSS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MLSS is expected to report earnings to 0 cents per share on March 27

Milestone Scientific MLSS Stock Earnings Reports
Q4'25
Est.
$-0.01
Q3'25
Beat
by $0.01
Q2'25
Missed
by $0.01
Q1'25
Est.
$-0.02
Q4'24
Missed
by $0.01
The last earnings report on November 13 showed earnings per share of 0 cents, beating the estimate of -1 cents. With 191.85K shares outstanding, the current market capitalization sits at 27.07M.
A.I. Advisor
published General Information

General Information

a provider of subcutaneous injection technology for dental and medical applications

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
425 Eagle Rock Avenue
Phone
+1 973 535-2717
Employees
17
Web
https://www.milestonescientific.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INGM22.000.58
+2.71%
Ingram Micro Holding Corp
RGCO22.550.51
+2.31%
RGC Resources
ABNB120.131.63
+1.38%
Airbnb
PFAI2.260.02
+0.67%
Pinnacle Food Group Limited
REX33.50-0.19
-0.56%
REX American Resources Corp

MLSS and Stocks

Correlation & Price change

A.I.dvisor tells us that MLSS and ANGO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MLSS and ANGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLSS
1D Price
Change %
MLSS100%
+2.47%
ANGO - MLSS
29%
Poorly correlated
+0.90%
ESTA - MLSS
26%
Poorly correlated
+0.41%
SRDX - MLSS
26%
Poorly correlated
N/A
QDEL - MLSS
25%
Poorly correlated
+3.77%
GKOS - MLSS
25%
Poorly correlated
+1.31%
More

Groups containing MLSS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLSS
1D Price
Change %
MLSS100%
+2.47%
Pharmaceuticals: Other
industry (103 stocks)
21%
Poorly correlated
+0.27%
Pharmaceuticals
industry (377 stocks)
18%
Poorly correlated
+0.44%